OTCMKTS:MRMD MariMed (MRMD) Stock Price, News & Analysis $0.16 -0.01 (-5.88%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.16▼$0.1750-Day Range$0.16▼$0.2552-Week Range$0.16▼$0.55Volume448,420 shsAverage Volume444,425 shsMarket Capitalization$60.75 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get MariMed alerts: Email Address Ad Porter & CompanyObama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.” Please, watch this now before it’s too late. About MariMed Stock (OTCMKTS:MRMD)MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.Read More MRMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MRMD Stock News HeadlinesJuly 22, 2024 | globenewswire.comMariMed Commences Operations In Newly Expanded Area of Maryland Cultivation FacilityJuly 9, 2024 | globenewswire.comMariMed Announces Second Quarter 2024 Earnings DateJuly 26, 2024 | Behind the Markets (Ad)Rare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED will cut rates any day now. But there's one indicator that's flashing a BIG warning sign to investors.July 2, 2024 | globenewswire.comMariMed Announces Approval of Adult-Use Sales At Panacea Wellness Dispensary in Quincy, Massachusetts and Updates for Ohio and MarylandJuly 2, 2024 | globenewswire.comMariMed Closes Acquisition of Second Maryland DispensaryMay 22, 2024 | markets.businessinsider.comCannabis Rescheduling Signals Strong Returns, Tax Breaks Could Increase This Stock's Market Cap By 170%May 14, 2024 | markets.businessinsider.comAnalysts May Need To Revise Cannabis Stock Projections For 2024: 10 Companies Surpass EBITDA Estimates By $37MMay 13, 2024 | benzinga.comCannabis Chart Of The Week: Analysts React Meekly To Strong Q1'24 EarningsJuly 26, 2024 | Behind the Markets (Ad)Rare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED will cut rates any day now. But there's one indicator that's flashing a BIG warning sign to investors.May 10, 2024 | finance.yahoo.comMariMed Inc. (PNK:MRMD) Q1 2024 Earnings Call TranscriptMay 9, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: MariMed (MRMD), Trevi Therapeutics (TRVI)May 9, 2024 | finanznachrichten.deMariMed Inc.: MariMed Reports First Quarter 2024 EarningsMay 9, 2024 | msn.comMRMD Stock Earnings: MariMed Beats Revenue for Q1 2024May 9, 2024 | msn.comQ1 2024: MariMed's Revenue Rises To $37.9M, Amid Declining Gross MarginMay 9, 2024 | markets.businessinsider.comQ1 2024: MariMed's Revenue Rises To $37.9M, Shrinks Losses While Increasing Wholesale RevenueMay 8, 2024 | globenewswire.comMariMed Reports First Quarter 2024 EarningsApril 30, 2024 | msn.comCannabis Industry Leaders React To DEA's Historic Move To Reschedule CannabisApril 30, 2024 | finance.yahoo.comStatement From MariMed CEO And President Jon Levine Regarding The Drug Enforcement Administration’s Decision To Recategorize Cannabis To Schedule IIISee More Headlines Receive MRMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:MRMD CUSIPN/A CIK1522767 Webmarimedadvisors.com Phone(617) 795-5140FaxN/AEmployees260Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,030,000.00 Net Margins-10.97% Pretax Margin-5.28% Return on Equity-2.75% Return on Assets-1.06% Debt Debt-to-Equity Ratio1.01 Current Ratio1.55 Quick Ratio0.73 Sales & Book Value Annual Sales$148.60 million Price / Sales0.43 Cash Flow$0.03 per share Price / Cash Flow5.91 Book Value$0.19 per share Price / Book0.89Miscellaneous Outstanding Shares379,670,000Free Float301,649,000Market Cap$64.47 million OptionableNot Optionable Beta2.80 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. Jon R. Levine (Age 59)Co-Founder, CEO, Interim CFO, President, Secretary, Treasurer & Director Comp: $390.5kMr. Timothy Shaw (Age 46)Chief Operating Officer Comp: $346.62kMr. Jonathan W. Rider (Age 59)Chief Information Officer Mr. Steve Wayne WestVice President of Investor RelationsMr. Howard SchacterChief Communications OfficerMr. Ryan CrandallChief Revenue OfficerMr. Charles Holt FinnieChief Strategy OfficerMore ExecutivesKey CompetitorsImmutepNASDAQ:IMMPActinium PharmaceuticalsNYSEAMERICAN:ATNMESSA PharmaNASDAQ:EPIXAcrivon TherapeuticsNASDAQ:ACRVChromaDexNASDAQ:CDXCView All Competitors MRMD Stock Analysis - Frequently Asked Questions How have MRMD shares performed this year? MariMed's stock was trading at $0.2748 on January 1st, 2024. Since then, MRMD shares have decreased by 41.8% and is now trading at $0.16. View the best growth stocks for 2024 here. How were MariMed's earnings last quarter? MariMed Inc. (OTCMKTS:MRMD) issued its earnings results on Monday, November, 15th. The company reported $0.01 earnings per share for the quarter. The firm earned $33.21 million during the quarter. MariMed had a negative trailing twelve-month return on equity of 2.75% and a negative net margin of 10.97%. How do I buy shares of MariMed? Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of MariMed own? Based on aggregate information from My MarketBeat watchlists, some other companies that MariMed investors own include KushCo (KSHB), Organigram (OGI), Auxly Cannabis Group (CBWTF), CNBX Pharmaceuticals (CNBX), Supreme Cannabis (SPRWF), Pennsylvania Real Estate Investment Trust (PEI). This page (OTCMKTS:MRMD) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MariMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MariMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRMD Stock Alerts